LEADER 04602nam 22006975 450 001 9910298319703321 005 20200630004146.0 010 $a3-642-53833-9 024 7 $a10.1007/978-3-642-53833-9 035 $a(CKB)3710000000111957 035 $a(EBL)1731232 035 $a(OCoLC)881510471 035 $a(SSID)ssj0001237152 035 $a(PQKBManifestationID)11735390 035 $a(PQKBTitleCode)TC0001237152 035 $a(PQKBWorkID)11267751 035 $a(PQKB)10214192 035 $a(MiAaPQ)EBC1731232 035 $a(DE-He213)978-3-642-53833-9 035 $a(PPN)178784621 035 $a(EXLCZ)993710000000111957 100 $a20140508d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAntibiofilm Agents$b[electronic resource] $eFrom Diagnosis to Treatment and Prevention /$fedited by Kendra P. Rumbaugh, Iqbal Ahmad 205 $a1st ed. 2014. 210 1$aBerlin, Heidelberg :$cSpringer Berlin Heidelberg :$cImprint: Springer,$d2014. 215 $a1 online resource (495 p.) 225 1 $aSpringer Series on Biofilms,$x1863-9607 ;$v8 300 $aDescription based upon print version of record. 311 $a1-322-04096-6 311 $a3-642-53832-0 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aPart I: Medical Biofilms -- Biofilms in Disease -- The Use of DNA Methods to Characterize Biofilm Infection -- Imaging Biofilms in Tissue Specimens -- Mechanisms of Drug Resistance in Fungi and Their Significance in Biofilms -- Horizontal Gene Transfer in Planktonic and Biofilm Modes -- The Role of Quorum Sensing in Biofilm Development -- Part II: Strategies for Biofilm Control -- Current and Emergent Control Strategies for Medical Biofilms -- The Effect of Plasmids and Other Biomolecules on the Effectiveness of Antibiofilm Agents -- Antimicrobial Coatings to Prevent Biofilm Formation on Medical Devices -- Medicinal Plants and Phytocompounds: A Potential Source of Novel Antibiofilm Agents -- Staphylococcus Aureus Biofilm Formation and Inhibition -- Novel Targets for Treatment Of Pseudomonas Aeruginosa Biofilms -- Inhibition of Fungal Biofilms -- Biofilm Control Strategies in Dental Health -- Inhibition of Polymicrobial Biofilms: Recent Trends -- Antibiofilm Strategies in the Food Industry -- Part III: The Future of Antibiofilm Agents -- Biofilm Inhibition by Nanoparticles -- Drug Delivery Systems That Eradicate and/or Prevent Biofilm Formation -- Eradication of Wound Biofilms by Electrical Stimulation -- The Effects of Photodynamic Therapy in Oral Biofilms -- Clinical and Regulatory Development of Antibiofilm Drugs: The Need, The Potential and The Challenges. 330 $aThis book provides a survey of recent advances in the development of antibiofilm agents for clinical and environmental applications. The fact that microbes exist in structured communities called biofilms has slowly become accepted within the medical community. We now know that over 80% of all infectious diseases are biofilm-related; however, significant challenges still lie in our ability to diagnose and treat these extremely recalcitrant infections. Written by experts from around the globe, this book offers a valuable resource for medical professionals seeking to treat biofilm-related disease, academic and industry researchers interested in drug discovery, and instructors who teach courses on microbial pathogenesis and medical microbiology. 410 0$aSpringer Series on Biofilms,$x1863-9607 ;$v8 606 $aMicrobiology 606 $aMedical microbiology 606 $aInfectious diseases 606 $aMicrobiology$3https://scigraph.springernature.com/ontologies/product-market-codes/L23004 606 $aMedical Microbiology$3https://scigraph.springernature.com/ontologies/product-market-codes/B16003 606 $aInfectious Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33096 615 0$aMicrobiology. 615 0$aMedical microbiology. 615 0$aInfectious diseases. 615 14$aMicrobiology. 615 24$aMedical Microbiology. 615 24$aInfectious Diseases. 676 $a616.9041 702 $aRumbaugh$b Kendra P$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aAhmad$b Iqbal$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910298319703321 996 $aAntibiofilm Agents$92537235 997 $aUNINA